Transgenic mouse models of lymphoma for preclinical analysis of novel anti-cancer drugs.

被引:0
|
作者
Pedersen, IM
Zapata, JM
Sporn, M
Carson, DA
Leoni, LM
Reed, JC
机构
[1] Burnham Inst, La Jolla, CA 92037 USA
[2] Dartmouth Coll Sch Med, Hanover, NH USA
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Salmedix Inc, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1365
引用
收藏
页码:352A / 352A
页数:1
相关论文
共 50 条
  • [31] An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
    Colvin, Emily K.
    Hudson, Amanda L.
    Anderson, Lyndsey L.
    Kumar, Ramyashree Prasanna
    McGregor, Iain S.
    Howell, Viive M.
    Arnold, Jonathon C.
    CANCERS, 2022, 14 (15)
  • [32] EGFR-targeted anti-cancer drugs in radiotherapy:: Preclinical evaluation of mechanisms
    Baumann, Michael
    Krause, Mechthild
    Dikomey, Ekkehard
    Dittmann, Klaus
    Doerr, Wolfgang
    Kasten-Pisula, Ulla
    Rodemann, H. Peter
    RADIOTHERAPY AND ONCOLOGY, 2007, 83 (03) : 238 - 248
  • [33] Array of translational systems pharmacodynamic models of anti-cancer drugs
    Ait-Oudhia, Sihem
    Mager, Donald E.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 (06) : 549 - 565
  • [34] Array of translational systems pharmacodynamic models of anti-cancer drugs
    Sihem Ait-Oudhia
    Donald E. Mager
    Journal of Pharmacokinetics and Pharmacodynamics, 2016, 43 : 549 - 565
  • [35] Platinum(II) and Palladium(II) Complex Compounds as Anti-cancer Drugs. Methods of Cytotoxicity Determination
    Pranczk, Joanna
    Jacewicz, Dagmara
    Wyrzykowski, Dariusz
    Chmurzynski, Lech
    CURRENT PHARMACEUTICAL ANALYSIS, 2014, 10 (01) : 2 - 9
  • [36] Systematic Repurposing Screening in Xenograft Models Identifies Approved Drugs with Novel Anti-Cancer Activity
    Roix, Jeffrey J.
    Harrison, S. D.
    Rainbolt, Elizabeth A.
    Meshaw, Kathryn R.
    McMurry, Avery S.
    Cheung, Peter
    Saha, Saurabh
    PLOS ONE, 2014, 9 (08):
  • [37] Synthesis and reactivity of chiral bisoxazoline platinum (II) complexes: Design of potential anti-cancer drugs.
    Schofield, MH
    Wvdysh, J
    Lee, AL
    Eterkin, JA
    Larabee, KS
    van der Geer, EPL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U792 - U792
  • [38] Teratogens as anti-cancer drugs
    Blagosklonny, MV
    CELL CYCLE, 2005, 4 (11) : 1518 - 1521
  • [39] Development of Anti-cancer Drugs
    Arrondeau, Jennifer
    Gan, Hui K.
    Razak, Albiruni R. A.
    Paoletti, Xavier
    Le Tourneau, Christophe
    DISCOVERY MEDICINE, 2010, 10 (53) : 355 - 362
  • [40] HANDLING ANTI-CANCER DRUGS
    不详
    LANCET, 1983, 1 (8323): : 543 - 543